202 related articles for article (PubMed ID: 32705260)
1. TGF‑β1‑induced epithelial‑mesenchymal transition increases fatty acid oxidation and OXPHOS activity via the p‑AMPK pathway in breast cancer cells.
Liu QQ; Huo HY; Ao S; Liu T; Yang L; Fei ZY; Zhang ZQ; Ding L; Cui QH; Lin J; Yu M; Xiong W
Oncol Rep; 2020 Sep; 44(3):1206-1215. PubMed ID: 32705260
[TBL] [Abstract][Full Text] [Related]
2. Leptin promotes fatty acid oxidation and OXPHOS via the c-Myc/PGC-1 pathway in cancer cells.
Liu Q; Sun Y; Fei Z; Yang Z; Duan K; Zi J; Cui Q; Yu M; Xiong W
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):707-714. PubMed ID: 31187140
[TBL] [Abstract][Full Text] [Related]
3. Diallyl disulfide inhibits TGF‑β1‑induced upregulation of Rac1 and β‑catenin in epithelial‑mesenchymal transition and tumor growth of gastric cancer.
Su B; Su J; Zeng Y; Ding E; Liu F; Tan T; Xia H; Wu YH; Zeng X; Ling H; Jiang H; Ai XH; Su Q
Oncol Rep; 2018 Jun; 39(6):2797-2806. PubMed ID: 29620286
[TBL] [Abstract][Full Text] [Related]
4. Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
Linher-Melville K; Zantinge S; Sanli T; Gerstein H; Tsakiridis T; Singh G
BMC Cancer; 2011 Feb; 11():56. PubMed ID: 21294903
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of BMP‑7 reverses TGF‑β1‑induced epithelial‑mesenchymal transition by attenuating the Wnt3/β‑catenin and TGF-β1/Smad2/3 signaling pathways in HK‑2 cells.
Song Y; Lv S; Wang F; Liu X; Cheng J; Liu S; Wang X; Chen W; Guan G; Liu G; Peng C
Mol Med Rep; 2020 Feb; 21(2):833-841. PubMed ID: 31974602
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
7. Sphingomyelin synthase 1 regulates the epithelial‑to‑mesenchymal transition mediated by the TGF‑β/Smad pathway in MDA‑MB‑231 cells.
Liu S; Hou H; Zhang P; Wu Y; He X; Li H; Yan N
Mol Med Rep; 2019 Feb; 19(2):1159-1167. PubMed ID: 30535436
[TBL] [Abstract][Full Text] [Related]
8. Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition.
Jiang L; Xiao L; Sugiura H; Huang X; Ali A; Kuro-o M; Deberardinis RJ; Boothman DA
Oncogene; 2015 Jul; 34(30):3908-16. PubMed ID: 25284588
[TBL] [Abstract][Full Text] [Related]
9. Febuxostat inhibits TGF‑β1‑induced epithelial‑mesenchymal transition via downregulation of USAG‑1 expression in Madin‑Darby canine kidney cells in vitro.
Lu L; Zhu J; Zhang Y; Wang Y; Zhang S; Xia A
Mol Med Rep; 2019 Mar; 19(3):1694-1704. PubMed ID: 30628645
[TBL] [Abstract][Full Text] [Related]
10. Silibinin attenuates TGF‑β1‑induced migration and invasion via EMT suppression and is associated with COX‑2 downregulation in bladder transitional cell carcinoma.
Li F; Sun Y; Jia J; Yang C; Tang X; Jin B; Wang K; Guo P; Ma Z; Chen Y; Wang X; Chang L; He D; Zeng J
Oncol Rep; 2018 Dec; 40(6):3543-3550. PubMed ID: 30272315
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR‑483‑5p inhibits TGF‑β1‑induced EMT by targeting RhoGDI1 in pulmonary fibrosis.
Huang G; Zhang J; Qing G; Liu D; Wang X; Chen Y; Wu Y; Li Y; Guo S
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34080651
[TBL] [Abstract][Full Text] [Related]
12. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
13. Hydroxypropyl‑β‑cyclodextrin attenuates the epithelial‑to‑mesenchymal transition via endoplasmic reticulum stress in MDA‑MB‑231 breast cancer cells.
Wu Y; Zhao Y; He X; He Z; Wang T; Wan L; Chen L; Yan N
Mol Med Rep; 2020 Jan; 21(1):249-257. PubMed ID: 31746388
[TBL] [Abstract][Full Text] [Related]
14. TUFM downregulation induces epithelial-mesenchymal transition and invasion in lung cancer cells via a mechanism involving AMPK-GSK3β signaling.
He K; Guo X; Liu Y; Li J; Hu Y; Wang D; Song J
Cell Mol Life Sci; 2016 May; 73(10):2105-21. PubMed ID: 26781467
[TBL] [Abstract][Full Text] [Related]
15. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of AMPKα2 impairs epithelial‑mesenchymal transition in rat renal tubular epithelial cells by downregulating ETS1 and RPS6KA1.
Yin X; Ma F; Fan X; Zhao Q; Liu X; Yang Y
Mol Med Rep; 2020 Dec; 22(6):4619-4628. PubMed ID: 33173986
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid synthase mediates the epithelial-mesenchymal transition of breast cancer cells.
Li J; Dong L; Wei D; Wang X; Zhang S; Li H
Int J Biol Sci; 2014; 10(2):171-80. PubMed ID: 24520215
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of invasion and epithelial-mesenchymal transition of human breast cancer cells by hydrogen sulfide through decreased phospho-p38 expression.
Lv M; Li Y; Ji MH; Zhuang M; Tang JH
Mol Med Rep; 2014 Jul; 10(1):341-6. PubMed ID: 24756435
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-α.
Huang M; Fu M; Wang J; Xia C; Zhang H; Xiong Y; He J; Liu J; Liu B; Pan S; Liu F
Biochem Pharmacol; 2021 Jun; 188():114527. PubMed ID: 33741330
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species induce epithelial‑mesenchymal transition, glycolytic switch, and mitochondrial repression through the Dlx‑2/Snail signaling pathways in MCF‑7 cells.
Lee SY; Ju MK; Jeon HM; Lee YJ; Kim CH; Park HG; Han SI; Kang HS
Mol Med Rep; 2019 Sep; 20(3):2339-2346. PubMed ID: 31322179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
